Abstract
Adseverin is an actin-severing/capping protein that may contribute to osteoclast differentiation in vitro but its role in bone remodeling of healthy animals is not defined. We analyzed bone and osteoclast structure in adseverin conditional null mice at alveolar and long bone sites. In wild-type and adseverin null mice, as measured by dual-energy X-ray absorptiometry, there were no differences of bone mineral content or bone mineral density, indicating no change of bone metabolism. In tibiae, TRAcP+ osteoclasts were formed in comparable numbers in adseverin null and wild-type mice. Ultrastructural analysis showed normal and similar abundance of ruffled borders, sealing zones, and mitochondria, and with no difference of osteoclast nuclear numbers. In contrast, analyses of long bone showed that in the absence of adseverin osteoclasts were smaller (120 ± 13 vs. 274 ± 19 µm2; p < 0.05), as were nuclear size and the surface area of cytoplasm. The nuclei of adseverin null osteoclasts exhibited more heterochromatin (31 ± 3%) than wild-type cells (8 ± 1%), suggesting that adseverin affects cell differentiation. The data indicate that in healthy, developing tissues, adseverin contributes to the regulation of osteoclast structure but not to bone metabolism in vivo.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Bone remodeling is a dynamic, life-long process in which bone formation by osteoblasts and bone resorption by osteoclasts are balanced to maintain a steady state. Osteoclasts are multinucleated resorptive cells of bone [1] that contribute to the maintenance of bone homeostasis. Osteoclasts are formed by fusion of monocyte/macrophage lineage precursor cells under the control of macrophage colony stimulating factor (M-CSF), which regulates the survival and proliferation of precursors [2], and by receptor activator of nuclear factor-kappa B ligand (RANKL), which promotes osteoclast differentiation and bone resorptive activity [3–5].
During osteoclastogenesis, the tight control of actin filament organization is crucial for cell formation, fusion, and differentiation and for cell attachment to bone surfaces. Notably, there are two structures in osteoclasts that are enriched with actin filaments: podosomes and sealing zones [6]. In early stages of osteoclastogenesis, podosomes are organized as clusters, which associate into actin rings that eventually form belts at the osteoclast periphery. Sealing zones form when osteoclasts adhere to mineralized bone surfaces, after which bone resorption is initiated [6, 7]. The organization and maintenance of these structures in osteoclasts is very dependent on the appropriate formation of actin filaments, which in turn requires temporally and spatially appropriate activities of actin-binding proteins.
There are hundreds of actin-binding proteins, which include the gelsolin family of actin-severing and actin-capping proteins that contribute to actin filament remodeling in a calcium-dependent manner [8, 9]. Gelsolin is involved in osteoclast function since compared to wild type, gelsolin-deficient mice exhibit increased bone mass and bone strength and defective podosome assembly in osteoclasts [10]. During osteoclastogenesis, gelsolin expression levels are relatively constant, while in cultured cells the expression of the gelsolin family protein adseverin is dramatically increased [11]. More recent data indicate that adseverin is important in osteoclastogenesis and may be an essential regulator of osteoclastic activity [11–13].
Adseverin (also known as scinderin) is an actin-severing/capping protein that has been studied in depth in chromaffin cells of the adrenal medulla [14]. The severing function of adseverin helps control actin filament length, while the actin-capping function of adseverin stabilizes actin filaments. Adseverin is highly expressed in many types of secretory cells, platelets [15], chondrocytes [16], odontoblasts [17], and differentiating osteoclasts [18]. Adseverin stimulates osteoclast differentiation and cell–cell fusion in cultured cells; the expression of adseverin is also increased in RANKL-induced osteoclastogenesis [11–13]. Adseverin knockdown inhibits bone resorption, reduces the secretion of TRAcP and cathepsin K, and alters actin filament organization [11, 13]. The increased expression of adseverin in osteoclastogenesis is dependent on the nuclear factor-kappa B (NF-κB) signaling pathway and on the expression of the osteoclastogenic transcription factor NFATc1 [13]. Adseverin co-localizes with actin filaments in podosomes; in adseverin knockout mice, osteoclasts exhibit lower number of podosome belts [12]. While these data suggest an important role for adseverin in osteoclastogenesis in vitro, it is not known whether adseverin impacts bone structure in healthy animals.
Here we examined bones from adseverin conditional null mice and background-matched wild-type mice by light microscopy, dual-energy X-ray absorptiometry (DEXA), and transmission electron microscopy (TEM). Since osteoclast function may differ in different skeletal sites [19–21], we compared osteoclast structure in alveolar bone with long bone and in healthy and inflamed sites.
Methods and Materials
Adseverin Knockout Mouse Model
All animal experiments were carried out in accordance with the Guide for the Humane Use and Care of Laboratory Animals and were approved by the University of Toronto Animal Care Committee. The generation of adseverin conditional knockout (adseverin KO) mice is described elsewhere [12]. In brief, mice harboring the conditional allele of adseverin were obtained by creation of a targeting vector that interrupted the expression of adseverin. After introduction of the targeting construct, LoxP floxed adseverin C57BL/6 mice were crossed with TRAcP-Cre C57 mice (from Christine M. Hachfeld, Mayo Clinic, Rochester, MN). The male mice generated by this breeding were further back-crossed with the pure LoxP floxed adseverin females. Littermates that did not express TRAcP-Cre are designated here as wild type (WT). The effectiveness of the knockout was confirmed by expression of TRAcP-Cre and LoxP by PCR. The primers that were used to genotype the adseverin mice were as follows: Cre expression: Forward: 5′-GAGTGATGAGGTTCGCAAGA-3′; Reverse: 5′-CTACACCAGAGACGGAAATC-3′; Product size: 635 bp. Distal LoxP: SCAD3: 5′-GTTAGTATTCCTCACTGGCACCC-3′; Ads-SDL2: 5′ ATGTTTCAGGACAGGAGTCTGAGC-3′; Presence of the distal LoxP: 363 bp; Wild-type adseverin allele: 289 bp. Around the left upper first molar, inflammation was induced by bacteria ligature in both WT and adseverin KO mice to compare the phenotype of that in the right part of the same mouse.
Dual-Energy X-ray Absorptiometry
DEXA was performed on 3-month-old mice after CO2 asphyxiation, using an animal PIXImus densitometer (Lunar; GE). Data for bone mineral density (BMD) and bone mineral content (BMC) were collected for the lumbar vertebrae, right femur, and the entire skeleton after masking of the heads by a single operator.
TRAcP Staining and Image Analysis
Distal tibia were removed, fixed with 4% paraformaldehyde (PFA), and decalcified in 10% EDTA (pH 7.4) at 4 °C for 2 weeks. After dehydration, the samples were embedded in paraffin and sectioned (5 µm thick). TRAcP staining was performed to assess the presence of osteoclasts. Osteoclasts were visualized with a Nikon Eclipse E1000 microscope and images were obtained with a Hamamatsu ORCA-ER camera and processed using Simple PCI software (Version 5.2.1.1609; Compix Inc). Osteoclasts were recognized as TRAcP+ cells and the number of osteoclasts was counted relative to the bone surface, according to standardized histomorphometric methods [22].
Transmission Electron Microscopy
At 2 months of age, WT and adseverin KO mice were sacrificed. Mice were perfused with fixative (1% glutaraldehyde + 4% formaldehyde in 0.1 M sodium cacodylate buffer). Maxillae and long bones were collected and fixed in the same fixative. After decalcification in EDTA (pH = 7.2) for 14 days at room temperature, specimens were post-fixed with 1% OsO4 for 1 h. After subsequent washing in buffer, samples were dehydrated by an ethanol series. Specimens were embedded in epoxy resin (LX112). Resin-embedded specimens were trimmed and 1-µm thin sections were cut. Sections were stained with Richardson’s solution for light microscopic analysis (Leica DMRA). Image-Pro plus software (Media Cybernetics, Silver Spring, MD) was used to assess the size of osteoclasts.
After examining the sections by light microscopy, sites of interest were selected and ultrathin sections (80 nm) were cut with a diamond knife. The ultrathin sections were collected on Formvar-coated copper grids and counterstained with uranyl acetate and lead citrate. Micrographs were obtained with a Philips CM10 electron microscope. Size measurement of osteoclasts/nuclei/cytoplasm area was assessed by Image-Pro plus software (Media Cybernetics, Silver Spring, MD). Osteoclasts with ≥1 nucleus were used for analysis. Stereological analysis was performed according to Weibel et al. [23].
Statistical Analysis
Results were shown as mean ± SD. Each experiment had a sample size of n ≥ 3, unless otherwise stated. Mean of the measurements of each osteoclast/nuclei/cytoplasm was calculated per mouse and pooled to compare the difference between WT and adseverin KO. Statistical analysis was performed using GraphPad Prism (version 5.0; GraphPad Software, LaJolla, CA). Student’s t test was used to compare the data between WT and KO. Statistical significance was set at p < 0.05.
Results
Osteoclast Number and Bone Resorption
The effectiveness of conditional knockout of adseverin was confirmed by PCR (Fig. 1a). The role of adseverin in bone resorption in vivo is not well defined: previous micro-CT data showed no difference of bone structure between normal WT and adseverin KO mice [12], while in the same study adseverin null mice were protected from inflammation-mediated bone loss. To determine whether osteoclasts and their resorptive activity are dependent on adseverin, we analyzed TRAcP+ osteoclasts in long bones of WT and adseverin KO mice (Fig. 1c, d). The number of TRAcP+ osteoclasts per bone surface was not different between the two genotypes (Fig. 1b). DEXA analysis showed no difference of bone mineral density or bone mineral content of the whole body, vertebrae, or femurs between adseverin KO and WT mice at 3 months of age (Table 1). These data indicate that adseverin is not required for normal bone formation and remodeling.
Osteoclast Morphology
Alveolar Bone
Osteoclasts on the surface of the alveolar bone proper, and those located adjacent to the periodontal ligament, exhibited multiple nuclei and numerous mitochondria (Fig. 2). These features were similar for WT (Fig. 2a, c) and adseverin KO mice (Fig. 2b, d). In some samples in which silk ligatures were wrapped around the circumference of molar teeth to induce gingival inflammation, there were osteoclasts on the surface of the adjacent alveolar bone but there were no obvious differences of osteoclast structure between genotypes (Fig. 2c, d). Although there were abundant large osteoclasts on bone surfaces adjacent to inflamed gingival tissues, because of the low number of osteoclasts, we could not conduct meaningful statistical analysis of cell size.
Long Bone
We found large numbers of osteoclasts on bone and calcified cartilage surfaces adjacent to the growth plate of tibiae in WT and KO mice (Fig. 3a–d; see also Fig. 1). Most osteoclasts were found at the junction of the growth plate cartilage and trabecular bone and were always in close vicinity to blood vessel capillaries. There were no obvious ultrastructural differences between osteoclasts from WT mice and KO mice (Fig. 3e, f). Osteoclasts in WT and adseverin KO mice were tightly adherent to the bone surface and exhibited well-developed sealing zones and ruffled borders.
Ruffled Borders
As adseverin may be important for podosome structure and bone resorption in vitro [12], we examined ruffled borders in detail. Ruffled borders were well developed in osteoclasts of both genotypes and were readily apparent in alveolar bone (Fig. 4a–d) and long bone (Fig. 4e, f) of WT and KO mice. There were no obvious morphological differences between the genotypes. Experimentally induced inflammation did not affect the formation of ruffled borders in WT (Fig. 4c) or adseverin KO mice (Fig. 4d). At healthy and inflamed sites, ruffled borders exhibited long, finger-like extensions (about 2 µm long, 100–200 nm wide) and were enriched with vacuoles that are important in exocytosis and endocytosis in bone resorption [24].
Sealing Zones
Sealing zones were prominent in osteoclasts of WT and adseverin KO mice (Fig. 5a, b). The numbers of osteoclasts associated with bone surface were not different between the two genotypes (p = 0.25), indicating that adseverin does not contribute to osteoclast attachment to bone.
Osteoclast Size
Previous in vitro studies showed that osteoclasts generated from precursors derived from adseverin null mice were smaller [12]. In the present study, we analyzed the size of osteoclasts formed in vivo and found that adseverin KO mice had significantly smaller osteoclasts (Fig. 6). Osteoclasts in WT mice were 274 ± 19 µm2, while osteoclasts in adseverin KO mice were less than half of this size (120 ± 13 µm2; p < 0.001; Fig. 6a). Since osteoclast size is affected by cell fusion processes, the number of nuclei per cell was assessed. There was no difference in the numbers of nuclei per cell (Fig. 6b), indicating that adseverin does not affect the fusion of osteoclast precursor cells in normal bone in vivo. Further, consistent with their smaller size, osteoclasts from adseverin null mice exhibited smaller cytoplasmic area (Fig. 6c).
Nuclear Size and Chromatin Distribution
Overall assessment of the shapes of osteoclast nuclei in adseverin KO mice indicated marked differences between KO and wild-type mice (Fig. 7a–d). Osteoclast nuclei in WT mice were predominantly round or oval shaped with a smooth, nuclear membrane surface (Fig. 7a, c), while the nuclei of osteoclasts in adseverin KO mice exhibited prominent folds and indentations (Fig. 7b, d).
The spatial distributions of euchromatin and heterochromatin were affected by adseverin expression. The amount of heterochromatin, which is a tightly packed, electron-dense, transcriptionally inactive chromatin, was fourfold more abundant in osteoclast nuclei of adseverin KO mice (31 ± 3%) than WT mice (8 ± 1%) (Fig. 7e). Euchromatin, which is an electron-lucent, loosely packed transcriptionally active chromatin, showed the opposite distribution (Fig. 7f). Examination of nuclear size showed that osteoclast nuclei in adseverin KO mice were smaller than osteoclast nuclei in WT mice (Fig. 7g).
Discussion
Our findings indicate that the actin-capping/severing protein adseverin contributes to the maintenance of osteoclast size and nuclear chromatin organization. In the absence of adseverin expression, osteoclasts were smaller, and with reduced cytoplasmic area and nuclear size, suggesting that osteoclast structure is affected by adseverin-dependent regulation of the actin filament network. Indeed, previous studies indicated that actin filaments could control the volume [25] and growth of cells [26]. The actin cytoskeleton is a dynamic system that may serve as an interactive sensor in cell volume regulation to maintain actin filaments in equilibrium [27]. Actin filament organization may be linked to the extent of cell swelling, by either regulation of ion transport systems or interactions of actin-associated proteins with discrete plasma membrane domains [28]. Cantiello and colleagues suggested that interactions between actin and actin-severing/capping proteins influence the activity of Na+/K+ channels, which regulate the movement of water and affect cell volume [29]. We propose that when adseverin is not expressed, the organization of actin cytoskeletal structures is affected, which in turn affects osteoclast size but, remarkably, not podosome structure. Evidently, the stability and turnover of actin filament structures in osteoclasts is under the control of multiple regulatory systems, one of which is adseverin.
The reduced size of osteoclasts in vivo in adseverin KO mice is consistent with previous in vitro studies showing that osteoclasts generated from precursor cells obtained from adseverin null mice were smaller [11, 12]. The smaller size of these osteoclasts was considered to be a result of the impaired fusion capacity of osteoclast precursors. Our current data show that the number of nuclei per osteoclast did not differ between adseverin null and wild-type littermates, indicating that fusion was not affected in vivo.
Although actin is one of the most abundant proteins in the cytoplasm, new data show a role for nuclear actin in cell function and structure [30–32]. While adseverin has not been demonstrated in the nucleus, gelsolin [31] and the actin-capping protein CapG [33] have been reported in the nucleus. Actin is present in cells in globular (G-actin), oligomeric, or filamentous form. In the nucleus, actin is mainly found as G-actin or oligomers [34], which requires the action of severing proteins like gelsolin to generate short oligomers or monomers. Nuclear actin assembly can affect transcription [35], suggesting an important relationship between the organization of actin filaments and transcriptional regulation. Consistent with this notion, we found that in the absence of adseverin the packing of heterochromatin was increased. Since heterochromatin is thought to be transcriptionally inactive because of a high proportion of repetitious sequences [36, 37], adseverin may regulate transcription and potentially histone assembly, which is reflected in chromatin packing. Adseverin, possibly in combination with actin, may play a previously unrecognized role in the organization of chromatin in osteoclast nuclei.
One of the most prominent sites of actin cytoskeletal organization in the osteoclast is at the sealing zone, where cells are firmly attached to the bone surface, which is a prerequisite for efficient bone degradation [7]. While previous in vitro studies showed that adseverin affects podosome self-organization [12], we found no differences in the structure of sealing zones of osteoclasts between WT and adseverin KO mice. Further, osteoclasts in adseverin KO mice formed a normal ruffled border and with no effect on bone resorption compared with WT mice. These data are in agreement with a previous study in which micro-CT showed an unchanged bone phenotype in healthy adseverin KO mice [12]. We analyzed osteoclasts at different skeletal sites and compared normal bone with bone adjacent to sites with induced inflammation. The structure and function of osteoclasts from different skeletal sites can be quite different [19]. In vitro studies showed that osteoclasts generated from precursors derived from alveolar bone and from long bone exhibit marked differences in cell shape [20]. Here we found no measureable differences in osteoclasts at long bone and alveolar bone sites in WT and adseverin null conditional mice. Further studies are needed to elucidate this difference between in vitro and in vivo works.
Collectively, our findings indicate that although the actin-severing/capping protein, adseverin, does not contribute to bone metabolism in vivo, it plays an important role in the control of osteoclast size and in the organization of chromatin structure and nuclear size.
References
Hayashi S, Yamane T, Miyamoto A et al (1998) Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol 76:911–922. doi:10.1139/bcb-76-6-911
Fuller K, Owens JM, Jagger CJ et al (1993) Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178:1733–1744
Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176. doi:10.1016/S0092-8674(00)81569-X
Hsu H, Lacey DL, Dunstan CR et al (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540–3545. doi:10.1073/pnas.96.7.3540
Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40:251–264. doi:10.1016/j.bone.2006.09.023
Jurdic P, Saltel F, Chabadel A, Destaing O (2006) Podosome and sealing zone: specificity of the osteoclast model. Eur J Cell Biol 85:195–202. doi:10.1016/j.ejcb.2005.09.008
Saltel F, Chabadel A, Bonnelye E, Jurdic P (2008) Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation. Eur J Cell Biol 87:459–468. doi:10.1016/j.ejcb.2008.01.001
Silacci P, Mazzolai L, Gauci C et al (2004) Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61:2614–2623. doi:10.1007/s00018-004-4225-6
Sakurai T, Kurokawa H, Nonomura Y (1991) Comparison between the gelsolin and adseverin domain structure. J Biol Chem 266:15979–15983
Chellaiah M, Kizer N, Silva M et al (2000) Gelsolin deficiency blocks podosome assembly and produces increased bone mass and strength. J Cell Biol 148:665–678. doi:10.1083/jcb.148.4.665
Hassanpour S, Jiang H, Wang Y et al (2014) The actin binding protein adseverin regulates osteoclastogenesis. PLoS ONE 9:e109078. doi:10.1371/journal.pone.0109078
Jiang H, Wang Y, Viniegra A et al (2015) Adseverin plays a role in osteoclast differentiation and periodontal disease-mediated bone loss. FASEB J 29:2281–2291. doi:10.1096/fj.14-265744
Song M-K, Lee ZH, Kim H-H (2015) Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1. Exp Mol Med 47:e199. doi:10.1038/emm.2015.94
Hartwig JH, Kwiatkowski DJ (1991) Actin-binding proteins. Curr Opin Cell Biol 3:87–97
Zunino R, Li Q, Rosé SD et al (2001) Expression of scinderin in megakaryoblastic leukemia cells induces differentiation, maturation, and apoptosis with release of plateletlike particles and inhibits proliferation and tumorigenesis. Blood 98:2210–2219. doi:10.1182/blood.V98.7.2210
Nurminsky D, Magee C, Faverman L, Nurminskaya M (2007) Regulation of chondrocyte differentiation by actin-severing protein adseverin. Dev Biol 302:427–437. doi:10.1016/j.ydbio.2006.09.052
Li X, Jiang H, Huang Y et al (2015) Expression and function of the actin-severing protein adseverin in the proliferation, migration, and differentiation of dental pulp cells. J Endod 41:493–500. doi:10.1016/j.joen.2014.11.030
Yang G, Zaidi M, Zhang W et al (2008) Functional grouping of osteoclast genes revealed through microarray analysis. Biochem Biophys Res Commun 366:352–359. doi:10.1016/j.bbrc.2007.11.106
Everts V, de Vries TJ, Helfrich MH (2009) Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta 1792:757–765. doi:10.1016/j.bbadis.2009.05.004
Azari A, Schoenmaker T, de Souza Faloni AP et al (2011) Jaw and long bone marrow derived osteoclasts differ in shape and their response to bone and dentin. Biochem Biophys Res Commun 409:205–210. doi:10.1016/j.bbrc.2011.04.120
Jansen IDC, Mardones P, Lecanda F et al (2009) Ae2(a,b)-deficient mice exhibit osteopetrosis of long bones but not of calvaria. FASEB J 23:3470–3481. doi:10.1096/fj.08-122598
Dempster DW, Compston JE, Drezner MK et al (2013) Standardized nomenclature, symbols and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2–17. doi:10.1002/jbmr.1805
Weibel ER, Kistler GS, Scherle WF (1966) Practical stereological methods for morphometric cytology. J Cell Biol 30:23–38
Lucht U (1972) Cytoplasmic vacuoles and bodies of the osteoclast: an electron microscope study. Z Zellforsch Mikrosk Anat 135:229–244. doi:10.1007/BF00315128
Henson JH (1999) Relationships between the actin cytoskeleton and cell volume regulation. Microsc Res Tech 47:155–162. doi:10.1002/(SICI)1097-0029(19991015)47:2<155::AID-JEMT7>3.0.CO;2-T
Bunnell TM, Burbach BJ, Shimizu Y, Ervasti JM (2011) β-Actin specifically controls cell growth, migration, and the G-actin pool. Mol Biol Cell 22:4047–4058. doi:10.1091/mbc.E11-06-0582
Papakonstanti EA, Vardaki EA, Stournaras C (2000) Actin cytoskeleton: a signaling sensor in cell volume regulation. Cell Physiol Biochem 10:257–264
Mills JW, Schwiebert EM, Stanton BA (1994) Evidence for the role of actin filaments in regulating cell swelling. J Exp Zool 268:111–120. doi:10.1002/jez.1402680207
Cantiello HF (1995) Actin filaments stimulate the Na(+)–K(+)-ATPase. Am J Physiol 269:F637–F643
Chen M, Shen X (2007) Nuclear actin and actin-related proteins in chromatin dynamics. Curr Opin Cell Biol 19:326–330. doi:10.1016/j.ceb.2007.04.009
Ocampo J, Mondragón R, Roa-Espitia AL et al (2005) Actin, myosin, cytokeratins and spectrin are components of the guinea pig sperm nuclear matrix. Tissue Cell 37:293–308. doi:10.1016/j.tice.2005.03.003
Castano E, Philimonenko VV, Kahle M et al (2010) Actin complexes in the cell nucleus: new stones in an old field. Histochem Cell Biol 133:607–626. doi:10.1007/s00418-010-0701-2
Bettinger BT, Gilbert DM, Amberg DC (2004) Actin up in the nucleus. Nat Rev Mol Cell Biol 5:410–415. doi:10.1038/nrm1370
Kapoor P, Shen X (2014) Mechanisms of nuclear actin in chromatin remodeling complexes. Trends Cell Biol 24:238–246. doi:10.1016/j.tcb.2013.10.007
Serebryannyy LA, Parilla M, Annibale P et al (2016) Persistent nuclear actin filaments inhibit transcription by RNA polymerase II. J Cell Sci. doi:10.1242/jcs.195867
Richards EJ, Elgin SCR (2002) Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489–500. doi:10.1016/S0092-8674(02)00644-X
Huisinga KL, Brower-Toland B, Elgin SCR (2006) The contradictory definitions of heterochromatin: transcription and silencing. Chromosoma 115:110–122. doi:10.1007/s00412-006-0052-x
Acknowledgements
This research was funded by Euroclast, a Marie Curie FP7-People-2013-ITN (Grant 607446, 2013). The authors would like to thank Henk van Veen for the assistance in electron microscopy. The authors are grateful to Chunxiang Sun for mice genotyping, and Hongwei Jiang for the analysis of the TRAcP-stained sections.
Author Contributions
YC contributed to the experiment performance and data analysis as well as drafting of the manuscript. YW enrolled in DEXA experiment and critical reading of the manuscript. DIP helped with ultrathin section preparation. VE, CAM, SS, and MG performed critical reading of the manuscript and all authors approved the final version.
Funding
Funding was provided by Euroclast (Marie Curie FP7-People-2013-ITN (607446).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Yixuan Cao, Yongqiang Wang, Sara Sprangers, Daisy I. Picavet, Michael Glogauer, Christopher A. McCulloch, and Vincent Everts declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
All animal experiments were carried out in accordance with the Guide for the Humane Use and Care of Laboratory Animals and were approved by the University of Toronto Animal Care Committee. This article does not contain any studies with human participants performed by any of the authors.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Cao, Y., Wang, Y., Sprangers, S. et al. Deletion of Adseverin in Osteoclasts Affects Cell Structure But Not Bone Metabolism. Calcif Tissue Int 101, 207–216 (2017). https://doi.org/10.1007/s00223-017-0271-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-017-0271-6